Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Diagnostic procedures, such as radionuclide imaging using calcium-41 (41Ca)
chloride aqueous solution, may help predict progressive disease in patients with prostate
cancer and bone metastasis.
PURPOSE: This clinical trial is studying how well calcium-41 (41Ca) chloride aqueous solution
works in diagnosing patients with prostate cancer and bone metastasis.